Hikma Pharmaceutical | HIK - Loan Capital


Hikma Pharmaceutical reported $1.49B in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Almirall EUR 303.77M 21.04M Jun/2026
argenx SE USD 36M 432K Jun/2026
AstraZeneca USD 26.01B 46M Jun/2026
Autolus Therapeutics Ltd USD 277.27M 7.07M Mar/2026
Bayer EUR 31.16B 480M Jun/2026
Fresenius EUR 9.55B 1.24B Jun/2026
Genmab DKK 4.96B 28M Jun/2026
GlaxoSmithKline GBP 13.95B 65M Jun/2026
GRIFOLS EUR 7.17B 1.91B Jun/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lakefront Biotherapeutics EUR 4.77M 78K Jun/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 11.21B 406M Jun/2026
Orion EUR 103.4M 7.2M Jun/2026
Recordati EUR 1.69B 67.09M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 14.65B 806M Jun/2026
UCB EUR 2.18B 634M Dec/2025